Serum levels of galectin-3 in idiopathic inflammatory myopathies: a potential biomarker of disease activity

MLA

Eri Watanabe, et al. “Serum Levels of Galectin-3 in Idiopathic Inflammatory Myopathies: A Potential Biomarker of Disease Activity.” Rheumatology, vol. 60, Aug. 2020, pp. 322–32. EBSCOhost, https://doi.org/10.1093/rheumatology/keaa305.

APA

Eri Watanabe, Emiko Chiba, Takahisa Gono, Chihiro Terai, Kazunori Kato, & Shigeru Kotake. (2020). Serum levels of galectin-3 in idiopathic inflammatory myopathies: a potential biomarker of disease activity. Rheumatology, 60, 322–332. https://doi.org/10.1093/rheumatology/keaa305

Chicago

Eri Watanabe, Emiko Chiba, Takahisa Gono, Chihiro Terai, Kazunori Kato, and Shigeru Kotake. 2020. “Serum Levels of Galectin-3 in Idiopathic Inflammatory Myopathies: A Potential Biomarker of Disease Activity.” Rheumatology 60 (August): 322–32. doi:10.1093/rheumatology/keaa305.